Jump to content

Stephen K. Burley

From Wikipedia, the free encyclopedia

This is the current revision of this page, as edited by Citation bot (talk | contribs) at 07:58, 30 August 2023 (Add: date. | Use this bot. Report bugs. | Suggested by Abductive | Category:American Rhodes Scholars | #UCB_Category 449/553). The present address (URL) is a permanent link to this version.

(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)
Stephen Burley
Born1958 (age 65–66)
EducationUniversity of Western Ontario (BS)
Exeter College, Oxford (MS, PhD)
Harvard University (MD)
Scientific career
InstitutionsRutgers University
Lilly Research Laboratories
Rockefeller University
Howard Hughes Medical Institute
Thesis Molecular arrangement in viruses studied by X-ray and neutron scattering and other physical techniques  (1983)
Doctoral advisorAndrew Miller

Stephen Kevin Burley is a British-born scientist, naturalized in both Canada and the United States, specializing in oncology and structural biology. He is a University Professor and Henry Rutgers Chair at Rutgers, The State University of New Jersey. Burley directs the RCSB Protein Data Bank (a member of the Worldwide Protein Data Bank), the Center for Integrative Proteomics Research, and the Institute for Quantitative Biomedicine.

Career

[edit]

Burley has a Bachelor in physics from the University of Western Ontario[1] and a D.Phil from Oxford University, England in Molecular Biophysics as a Rhodes scholar.[2] Burley has an M.D. from Harvard Medical School.

He worked with Gregory A. Petsko and William N. Lipscomb at MIT and Harvard. He was faculty at Howard Hughes Medical Institute and Rockefeller University. Burley co-founded Prospect Genomics, Inc,[3] a computational genomics pharma. He was Chief Scientific Officer of SGX Pharmaceuticals after it acquired Prospect. SGX was in turn merged with Eli Lilly in 2008 where Burley was a Distinguished Lilly Research Scholar in Lilly Research Laboratories[4]

In 2012 Burley joined Rutgers [5] as Director of the Center for Integrative Proteomics Research and became director of the RCSB PDB (US regional data center for the worldwide PDB) in 2014, succeeding Prof. Helen Berman[6]

He is a member of the Editorial Board for Oncogene.[7]

Honors and awards

[edit]

References

[edit]
  1. ^ "Structural GenomiX Appoints Stephen K. Burley as Chief Scientific Officer -- re> SAN DIEGO, Oct. 16 /PRNewswire/ --". Archived from the original on 2014-10-13.
  2. ^ "Introducing Professor Stephen K. Burley | Department of Chemistry & Chemical Biology". Archived from the original on 2014-10-14. Retrieved 2014-10-08.
  3. ^ "Stocks". 30 August 2023.[dead link]
  4. ^ http://proteomics.rutgers.edu/public/?q=faculty/burley
  5. ^ "Rutgers recruits top researcher to head Center for Integrative Proteomics Research - NJBIZ". 17 December 2012.
  6. ^ "RCSB PDB - News". www.rcsb.org. Archived from the original on 2014-09-03.
  7. ^ "Editorial Board | Oncogene".